Premier Fund Managers LTD Biolife Solutions Inc Transaction History

Premier Fund Managers LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$10.81 - $22.96 $221,550 - $470,565	-20,495 Reduced 59.47%	13,970 $196,000
Q2 2023 Aug 03, 2023	SELL	$17.19 - $24.34 $201,294 - $285,021	-11,710 Reduced 25.36%	34,465 $778,000
Q1 2023 May 05, 2023	SELL	$17.67 - $26.07 $353,506 - $521,556	-20,006 Reduced 30.23%	46,175 $959,000
Q4 2022 Feb 09, 2023	SELL	$16.95 - $25.07 $2.29 Million - $3.38 Million	-134,819 Reduced 67.07%	66,181 $1.2 Million
Q4 2022 Feb 08, 2023	BUY	$16.95 - $25.07 $1.18 Million - $1.75 Million	69,819 Added 53.22%	201,000 $7.38 Million
Q2 2021 Aug 05, 2021	SELL	$29.51 - $44.62 $1.32 Million - $2 Million	-44,742 Reduced 25.43%	131,181 $5.7 Million
Q1 2021 May 10, 2021	BUY	$32.95 - $44.24 $5.8 Million - $7.78 Million	175,923 New	175,923 $6.33 Million

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

Stay updated on Premier Fund Managers LTD with notifications on news.